| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |